Disease MarkersPub Date : 2023-01-01DOI: 10.1155/2023/9805152
Disease Markers
{"title":"Retracted: Identification and Verification of Key Tumor Genes Associated with Diagnosis and Prognosis of Breast Cancer Based on Bioinformatics Analysis.","authors":"Disease Markers","doi":"10.1155/2023/9805152","DOIUrl":"https://doi.org/10.1155/2023/9805152","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2022/9041466.].</p>","PeriodicalId":11201,"journal":{"name":"Disease Markers","volume":"2023 ","pages":"9805152"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371733/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10245809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Disease MarkersPub Date : 2023-01-01DOI: 10.1155/2023/8564650
Wu Chen, Zhi-Yu Li, Lin Huang, Dong-Hai Zhou, Wen-Qing Luo, Xu-Feng Zhang, Lin Li, Cheng-Ping Wen, Qiao Wang
{"title":"Integrative Bioinformatics Analysis Identifies DDX60 as a Potential Biomarker for Systemic Lupus Erythematosus.","authors":"Wu Chen, Zhi-Yu Li, Lin Huang, Dong-Hai Zhou, Wen-Qing Luo, Xu-Feng Zhang, Lin Li, Cheng-Ping Wen, Qiao Wang","doi":"10.1155/2023/8564650","DOIUrl":"https://doi.org/10.1155/2023/8564650","url":null,"abstract":"<p><strong>Background: </strong>Systemic lupus erythematosus (SLE) is an autoimmune disease with strong heterogeneity, leading to variable clinical symptoms, which makes diagnosis and activity evaluation difficult.</p><p><strong>Methods: </strong>The original dataset of GSE88884 was analyzed to screen differentially expressed genes (DEGs) of SLE and the correlation between DEGs and clinical parameters (SLEDAI, anti-dsDNA, C3, and C4). The result was validated by microarray GSE121239 and SLE patients with RT-qPCR. Next, receiver operator characteristic (ROC) analysis, correlation analysis, and ordinal logistic regression were applied, respectively, to evaluate the capability of diagnosis and prediction of the candidate biomarker. Subsequently, the biological functions of the candidate biomarker were investigated through KEGG and GO enrichment, protein-protein interaction network, and the correlation matrix.</p><p><strong>Results: </strong>A total of 283 DEGs were screened, and seven of them were overlapped with SLE-related genes. DDX60 was identified as the candidate biomarker. Analyses of GSE88884, GSE121239, and SLE patients with RT-qPCR indicated that DDX60 expression level is significantly higher in patients with high disease activity. ROC analysis and the area under the ROC curve (AUC = 0.8818) suggested that DDX60 has good diagnostic performance. DDX60 expression level was positively correlated with SLEDAI scores (<i>r</i> = 0.24). For every 1-unit increase in DDX60 expression value, the odds of a higher stage of activity of SLE disease are multiplied by 1.47. The function of DDX60 mainly focuses on IFN-I-induced antiviral activities, RIG-I signaling, and innate immune. Moreover, DDX60 plays a synergistic role with DDX58, IFIH1, OASL, IFIT1, and other related genes in the SLE pathogenesis<i>. Conclusions</i>. DDX60 is differently expressed in SLE, and it is significantly related to both serological indicators and the disease activity of SLE. We suggested that DDX60 might be a potential biomarker for SLE diagnosis and management.</p>","PeriodicalId":11201,"journal":{"name":"Disease Markers","volume":"2023 ","pages":"8564650"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842429/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10567306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Disease MarkersPub Date : 2023-01-01DOI: 10.1155/2023/5223657
Cairu Gu, Xifeng Xiong, Wei Liu
{"title":"Prognostic Significance of the CXCLs and Its Impact on the Immune Microenvironment in Ovarian Cancer.","authors":"Cairu Gu, Xifeng Xiong, Wei Liu","doi":"10.1155/2023/5223657","DOIUrl":"https://doi.org/10.1155/2023/5223657","url":null,"abstract":"<p><p>The chemokine (C-X-C motif) ligand (CXCL) family in tumor tissue is closely related to tumor growth, metastasis, and survival. However, the differential expression profile and prognostic value of the CXCLs in ovarian cancer (OC) have not been elucidated. Therefore, we studied the expression levels and mutations of CXCLs in OC patient in TCGA and various public databases. The expression differences of CXCLs in OC cancer tissues and normal tissues were compared through the Gene Expression Profiling Interactive Analysis (GEPIA) database. The effect of CXCLs on OC prognosis was analyzed using the Kaplan-Meier curves in GEPIA database. The impact of CXCLs on immune infiltration and clinicopathological outcomes in OC was assessed using the TIMER algorithm. Compared with normal tissues, we found that eight CXCLs were significantly differentially expressed in OC. The expression levels of CXCL9 (<i>P</i> = 0.0201), CXCL11 (<i>P</i> = 0.0385), and CXCL13 (<i>P</i> = 0.0288) were significantly associated with tumor stage. CXCL13 was the only gene that significantly affected both disease-free survival (DFS) and overall survival (OS) in OC, and higher CXCL13 transcript levels implied longer DFS and OS. Although there was no significant impact on DFS, CXCL10 (<i>P</i> = 0.0079) and CXCL11 (<i>P</i> = 0.0011) expression levels had a significant effect on OS in OC. At the same time, CXCLs were significantly associated with several immune-infiltrating cells in OC tissues. The CXCLs were significantly associated with one or more immune-infiltrating cells in OC tissue. CXCL13 was differentially expressed in OC and significantly affected the prognosis of patients and was a potential marker of OC prognosis.</p>","PeriodicalId":11201,"journal":{"name":"Disease Markers","volume":"2023 ","pages":"5223657"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926335/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10740254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Disease MarkersPub Date : 2023-01-01DOI: 10.1155/2023/3413356
Qian Peng, Yiwen Xiao, Zhiguo Tian, Yunwei Yang, Jiang Deng, Jie Lin
{"title":"Remnant Cholesterol as an Independent Predictor of Periodontitis: A Population-Based Study.","authors":"Qian Peng, Yiwen Xiao, Zhiguo Tian, Yunwei Yang, Jiang Deng, Jie Lin","doi":"10.1155/2023/3413356","DOIUrl":"https://doi.org/10.1155/2023/3413356","url":null,"abstract":"<p><strong>Objective: </strong>Numerus studies present that remnant cholesterol (RC) as a risk factor participates in the progression of multiple diseases. The aim of this study was to assess the relationship between cholesterol and periodontitis in the US population to find a reliable lipid predictor for periodontitis.</p><p><strong>Materials and methods: </strong>Clinical data was retrieved from the National Health and Nutrition Examination Survey (NHANES) database between 2009 and 2014. The logistic regression was conducted to examine the corelationship between RC and various clinical features. Meanwhile, the dose-response relationship was measured through restricted cubic spline analysis. And the propensity score matching (PSM) was established to further investigate the potential relationship between RC and periodontitis.</p><p><strong>Results: </strong>A number of 4,829 eligible participants were included in this study. It was found that the increased RC is associated with the higher risk of periodontitis after adjusting the potential confounding factors with the adjusted odds ratios (aOR) of 1.403 (95% confidence intervals (CI): 1.171-1.681, <i>P</i> < 0.001, univariate analysis) and 1.341 (95% CI: 1.105-1.629, <i>P</i> = 0.003, multivariate analysis) in the highest grade. There were significant differences in the relationship between RC and various clinical features including age, gender, body mass index (BMI), race, hypertension, and diabetes mellitus (all <i>P</i> < 0.001). Besides, the calculated thresholds for predicting periodontitis were 19.99 (before propensity score matching (PSM)) and 20.91 (after PSM) mg/dL.</p><p><strong>Conclusions: </strong>In this study, RC was identified to be positively associated with the occurrence of periodontitis, which suggests that RC can be considered as a predictor for periodontitis.</p>","PeriodicalId":11201,"journal":{"name":"Disease Markers","volume":"2023 ","pages":"3413356"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943602/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10779136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Disease MarkersPub Date : 2023-01-01DOI: 10.1155/2023/9793869
Disease Markers
{"title":"Retracted: Comparison of Short-Term Restorative Effects and Periodontal Health Status of Restorations Made of Different Materials in Full-Crown Restoration of Mandibular Premolar Tooth Defects.","authors":"Disease Markers","doi":"10.1155/2023/9793869","DOIUrl":"https://doi.org/10.1155/2023/9793869","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2022/3682741.].</p>","PeriodicalId":11201,"journal":{"name":"Disease Markers","volume":"2023 ","pages":"9793869"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396540/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9992814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Disease MarkersPub Date : 2023-01-01DOI: 10.1155/2023/9862875
Disease Markers
{"title":"Retracted: Effects of Minocycline on Cognitive Impairment, Hippocampal Inflammatory Response, and Hippocampal Alzheimer's Related Proteins in Aged Rats after Propofol Anesthesia.","authors":"Disease Markers","doi":"10.1155/2023/9862875","DOIUrl":"https://doi.org/10.1155/2023/9862875","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2022/4709019.].</p>","PeriodicalId":11201,"journal":{"name":"Disease Markers","volume":"2023 ","pages":"9862875"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396533/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9992820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Disease MarkersPub Date : 2023-01-01DOI: 10.1155/2023/1702125
Ya Lu, Yuan Zhang, Xinyue Wang, Hui Zhang, Yue Zhu, Junying Zhang, Huanhuan Sha, Renrui Zou, Yujie Gan, Ying Sui, Juan Wang, Tongde Du, Jianzhong Wu, Jifeng Feng
{"title":"Aldolase A Promotes Colorectal Cancer Progression through Targeting COPS6 and Regulating MAPK Signaling Pathway.","authors":"Ya Lu, Yuan Zhang, Xinyue Wang, Hui Zhang, Yue Zhu, Junying Zhang, Huanhuan Sha, Renrui Zou, Yujie Gan, Ying Sui, Juan Wang, Tongde Du, Jianzhong Wu, Jifeng Feng","doi":"10.1155/2023/1702125","DOIUrl":"https://doi.org/10.1155/2023/1702125","url":null,"abstract":"<p><p>Colorectal cancer (CRC) is a serious threat to human health, and its underlying mechanisms remain to be further explored. Aldolase A (ALDOA) has received increasing attention for its reported association with multiple cancers, but the role and mechanisms of ALDOA in CRC are still unclear. In the current study, high expression levels and enzymatic activity of ALDOA were detected in CRC tissues and cell lines, indicating the clinical significance of ALDOA in human CRC. In addition, silencing ALDOA significantly impaired the proliferation and metastasis of CRC cells <i>in vitro</i> and <i>in vivo</i>. Mechanistically, immunoprecipitation assays and mass spectrometry analysis identified the binding protein COPS6 of ALDOA. Furthermore, the promoting effects of upregulated ALDOA on CRC cell proliferation and metastasis were inhibited by COPS6 depletion, demonstrating COPS6 was required for ALDOA in mediating CRC progress. Moreover, the epithelial-mesenchymal transition (EMT) program and MAPK signaling pathway were found to be activated by ALDOA overexpression as well. In summary, our findings suggested that ALDOA facilitated the proliferation and metastasis of CRC by binding and regulating COPS6, inducing EMT, and activating the mitogen-activated protein kinase (MAPK) signaling pathway. The present study provided evidence for ALDOA as a promising potential biomarker for CRC.</p>","PeriodicalId":11201,"journal":{"name":"Disease Markers","volume":"2023 ","pages":"1702125"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344634/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9826205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Characterization of TIM-3 Expression and Its Correlation with TNF-<i>α</i> and IFN-<i>γ</i> in Patients with Surgically Resected Lung Adenocarcinoma.","authors":"Jian Tan, Piao Shen, Xingping Yang, Weijie Cai, Hongying Liao","doi":"10.1155/2023/2352945","DOIUrl":"https://doi.org/10.1155/2023/2352945","url":null,"abstract":"<p><strong>Objective: </strong>T cell immunoglobulin and mucin-containing protein-3 (TIM-3) is an important immune checkpoint, but its role in lung cancer is still not clear. In this study, we investigated TIM-3 protein expression and its correlation with TNF-<i>α</i> and IFN-<i>γ</i> by examining the tissues of patients with lung adenocarcinoma.</p><p><strong>Methods: </strong>We detected the mRNA quantity of TIM-3, TNF-<i>α</i>, and IFN-<i>γ</i> in 40 surgically resected specimens from patients with lung adenocarcinoma by real-time quantitative polymerase chain reaction (qRT-PCR). The protein expression of TIM-3, TNF-<i>α</i>, and IFN-<i>γ</i> was assessed in normal tissues, paracarcinoma tissues, and tumor tissues by western blotting, respectively. The relevance between the expression and clinicopathological information of the patients was analyzed.</p><p><strong>Results: </strong>The results showed that the expression level of TIM-3 was higher in tumor tissues than normal tissues and paracancerous tissues (<i>P</i> < 0.05). On the contrary, the expression of TNF-<i>α</i> and IFN-<i>γ</i> in tumor tissues was lower than normal tissues and paracarcinoma tissues (<i>P</i> < 0.05). However, the expression levels of IFN-<i>γ</i> mRNA were not observed to be significantly different between cancerous tissues and adjacent tissues. While TIM-3 protein expression in cancer tissues of patients with lymph node metastasis was higher than in patients without metastasis, the expression of TNF-<i>α</i> and IFN-<i>γ</i> was lower (<i>P</i> < 0.05). Importantly, the expression of TIM-3 was negatively correlated with the expression of TNF-<i>α</i> and IFN-<i>γ</i>, and the expression of TNF-<i>α</i> was found to be positively correlated with IFN-<i>γ</i> in the patient.</p><p><strong>Conclusion: </strong>The high expression of TIM-3, the low expression of TNF-<i>α</i> and IFN-<i>γ</i>, and the synergistic effect of TNF-<i>α</i> and IFN-<i>γ</i> in patients with lung adenocarcinoma were closely related to poor clinicopathological characteristics. Overexpression of TIM-3 may play an important role in the relationship between TNF-<i>α</i> and IFN-<i>γ</i> secretion and poor clinicopathological characteristics.</p>","PeriodicalId":11201,"journal":{"name":"Disease Markers","volume":"2023 ","pages":"2352945"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974258/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9098209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}